The "Liquid Bx. Cell-Free EGFR T790M/L858R Exon 19 Deletion Test" is an advanced diagnostic procedure available at DNA Labs UAE, designed to detect specific mutations in the EGFR gene. These mutations, namely T790M, L858R, and the Exon 19 deletion, are critical in the context of lung cancer, particularly non-small cell lung cancer (NSCLC). This test is non-invasive as it utilizes a blood sample to identify cell-free DNA (cfDNA) fragments that carry these mutations, offering a valuable alternative to traditional tissue biopsy.
The detection of these mutations is pivotal for the personalized treatment of lung cancer, as they can influence the response to certain targeted therapies, making this test a crucial tool in the management of patients with NSCLC. The cost of the test at DNA Labs UAE is 3000 AED, reflecting the sophisticated technology and expertise required to accurately identify these genetic alterations. By providing a quick and minimally invasive diagnostic option, the Liquid Bx. Cell-Free EGFR T790M/L858R Exon 19 Deletion Test represents a significant advancement in the field of oncology, aiding in the selection of the most effective treatment strategies for patients.
The MECP2 Full Gene Mutation Analysis Rett Syndrome Test is a specialized genetic test designed to identify mutations in the MECP2 gene, which are strongly associated with Rett Syndrome, a rare neurodevelopmental disorder primarily affecting females. This comprehensive analysis helps in the early detection and diagnosis of Rett Syndrome, enabling timely intervention and management of the condition. Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing the entire MECP2 gene for any mutations. The cost of the test is 3000 AED, reflecting the advanced technology and expertise required to conduct this intricate analysis. By identifying specific genetic mutations, the test provides crucial information for families and healthcare providers, facilitating personalized care plans and improving the quality of life for those affected by Rett Syndrome.
The Ganglioside GM-1 Antibodies IgG and IgM Test is a specialized diagnostic assessment performed to detect the presence of antibodies against ganglioside GM-1 in the blood. Gangliosides are complex glycosphingolipids present in the cell membranes, and GM-1 plays a crucial role in neuronal function. The presence of IgG and IgM antibodies against GM-1 can be associated with various neurological disorders, including Guillain-Barré syndrome, multifocal motor neuropathy, and some forms of neuropathies.
This test is pivotal for the diagnosis and management of patients presenting with symptoms suggestive of autoimmune neuropathies. By measuring the levels of these specific antibodies, healthcare providers can gain valuable insights into the underlying causes of neurological symptoms, aiding in the formulation of an appropriate treatment plan.
Performed at DNA Labs UAE, a leading diagnostic facility known for its advanced testing capabilities and adherence to high-quality standards, the Ganglioside GM-1 Antibodies IgG and IgM Test ensures reliability and accuracy. The test cost is set at 3300 AED, reflecting the sophisticated nature of the assay and the specialized expertise required to interpret the results.
Patients undergoing this test can expect a straightforward blood draw, with results typically available within a specified timeframe post-collection. The outcome of this test, especially when combined with clinical evaluation and other diagnostic assessments, can significantly influence the therapeutic direction, potentially leading to improved patient outcomes in managing complex neurological conditions.
The Autoimmune Encephalitis Panel Serum Test is a sophisticated diagnostic tool used to identify specific antibodies that may be associated with autoimmune encephalitis, a condition where the body's immune system mistakenly attacks healthy brain cells, leading to inflammation and a range of neurological symptoms. This panel is crucial for diagnosing autoimmune encephalitis, which can present with symptoms such as seizures, memory issues, cognitive decline, psychiatric symptoms, and movement disorders. Early and accurate detection through this panel is vital for the effective management and treatment of the condition.
The test involves analyzing a serum sample, typically obtained from the patient's blood, to detect the presence of autoantibodies that target neuronal antigens. Identifying these antibodies can help differentiate autoimmune encephalitis from other neurological disorders, guiding healthcare professionals in tailoring the most appropriate treatment plans for their patients.
In the UAE, the Autoimmune Encephalitis Panel Serum Test is available at DNA Labs, a reputable facility known for its advanced diagnostic services. The cost of the test is 4270 AED, reflecting the comprehensive nature of the panel and the specialized technology and expertise required to perform it. Patients and healthcare providers looking to conduct this test can expect a reliable service that contributes significantly to the diagnosis and management of autoimmune encephalitis.
The Autoimmune Encephalitis Panel CSF Test is a diagnostic procedure designed to identify specific antibodies in the cerebrospinal fluid (CSF) that may indicate the presence of autoimmune encephalitis. This condition is characterized by the immune system mistakenly attacking healthy brain cells, leading to inflammation and a range of neurological symptoms such as seizures, memory problems, cognitive impairments, and psychiatric issues. The test is crucial for the accurate diagnosis and prompt treatment of autoimmune encephalitis, helping to differentiate it from other neurological disorders.
Performed at DNA Labs UAE, a leading laboratory known for its state-of-the-art facilities and expert medical team, the test ensures high accuracy and reliability. The cost of the Autoimmune Encephalitis Panel CSF Test is 4210 AED, reflecting the comprehensive nature of the panel and the sophisticated technology employed in the analysis. By identifying the specific antibodies associated with autoimmune encephalitis, this test plays a vital role in guiding the treatment plan and improving patient outcomes.
The Chronic Lymphocytic Leukemia (CLL) Prognostic Panel Test is a comprehensive diagnostic tool designed to assess the risk and progression of CLL, a type of cancer that affects the blood and bone marrow. This test is particularly crucial for individuals diagnosed with CLL as it helps in determining the aggressiveness of the disease and guides healthcare professionals in tailoring the most effective treatment strategies for the patient.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test involves analyzing specific genetic markers and mutations associated with CLL. These include chromosomal abnormalities, gene mutations, and expression levels of certain proteins that influence the behavior of the disease. By evaluating these parameters, the test provides valuable insights into the prognosis of CLL, helping predict the patient's response to treatment and potential survival outcomes.
The cost of the CLL Prognostic Panel Test at DNA Labs UAE is 4210 AED. This investment can be invaluable for patients and their families, offering them a clearer understanding of the disease's trajectory and enabling informed decisions regarding treatment options. DNA Labs UAE employs cutting-edge technology and expertise to ensure accurate and reliable results, making it a trusted choice for patients seeking comprehensive CLL diagnostics.
The "LPL Expert Panel 4 Test" is a specialized genetic test offered by DNA Labs UAE, designed to analyze the Lipoprotein Lipase (LPL) gene. This test is particularly important for individuals seeking insights into their genetic predisposition to lipid metabolism disorders, which can significantly impact heart health and overall well-being. The LPL gene plays a critical role in the body's ability to break down fats in the blood, and mutations in this gene can lead to conditions such as hyperlipidemia. By undergoing this test, patients can gain valuable information on their risk factors for developing such conditions, enabling them to take proactive steps in managing their health.
The test is priced at 4210 AED, reflecting the comprehensive analysis and detailed reporting that comes with it. Conducted at the state-of-the-art facilities of DNA Labs UAE, the test ensures accuracy and reliability, leveraging advanced genetic sequencing technologies. Upon completion, individuals receive a thorough report that not only highlights any detected mutations in the LPL gene but also provides guidance on potential lifestyle adjustments and medical interventions. This test is an essential tool for those with a family history of lipid metabolism disorders or anyone interested in a deeper understanding of their genetic health profile.
The Thalassemia Beta Trio Prenatal Mutation Detection Test is a specialized genetic screening procedure designed to identify mutations associated with beta-thalassemia in an unborn child. Conducted at DNA Labs UAE, this test plays a crucial role in early diagnosis, allowing for informed decisions and preparations by expectant parents. By analyzing fetal DNA alongside genetic material from both parents, the test accurately detects the presence of beta-thalassemia mutations, which can lead to a range of health issues from mild anemia to severe blood disorders in the child.
Priced at 4210 AED, the test is a significant investment in prenatal care, offering invaluable insights into the baby's health and genetic predispositions. The process involves collecting samples from the mother and the potential father, which are then meticulously examined for any genetic indicators of the condition. This early detection method not only facilitates better medical management but also supports families in understanding their future child's health needs. DNA Labs UAE, with its state-of-the-art facilities and expert geneticists, ensures high accuracy and reliability in the results, making it a trusted choice for expectant parents concerned about beta-thalassemia.
The "Abortion Panel Anti-HLA Antibodies Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to assess the presence of anti-human leukocyte antigen (HLA) antibodies in the blood. This test plays a crucial role in understanding the causes of recurrent spontaneous abortions, as the presence of these antibodies can indicate an immune response against the fetus, leading to pregnancy complications or loss. Priced at 4210 AED, the test is an important tool for couples facing difficulties in sustaining pregnancies, providing them with valuable insights that can guide medical interventions or treatments to improve pregnancy outcomes. DNA Labs UAE, known for its state-of-the-art facilities and expert medical professionals, ensures accurate and reliable test results, making it a trusted choice for individuals seeking comprehensive reproductive health assessments.
The Acute Myeloid Leukemia (AML) Cytogenetics Panel Test is a critical diagnostic tool offered by DNA Labs UAE, designed to identify chromosomal abnormalities associated with AML. This test plays a pivotal role in diagnosing, prognosticating, and guiding the treatment strategies for individuals suspected of having or diagnosed with AML. By analyzing the genetic material of cells from a blood or bone marrow sample, the test can detect various genetic mutations and alterations that are characteristic of AML. These findings can help in determining the specific subtype of AML, predict how the disease will progress, and identify the most effective treatment options. The cost of the AML Cytogenetics Panel Test at DNA Labs UAE is 4100 AED, reflecting the comprehensive analysis and detailed insights it provides, aiding in the personalized management of the disease.
